JSLL

Jeena Sikho Lifecare Limited

Ayurveda healthcare platform with Panchakarma hospitals and Ayurvedic products

Consumer Discretionary›Consumer Services›Leisure Services›Wellness

jeenasikho.com

Ask AI

Key metrics

Price as of 2026-10-16

Stock price

₹388.30

Market cap

4,831 Cr

Stock P/E

20.4

P/B

10.34

Dividend yield

0.3%

ROE (FY26)

47.5%

ROCE (FY26)

66.4%

Operating margin (FY26)

37.7%

Debt / equity (FY26)

0.0010

OCF / EBITDA (FY26)

72.6%

Full years shown; sign in free for the trailing twelve months. Learn about these metrics →

Price & valuation

Share price and valuation multiples (P/E, P/B and more) over time.

Loading price history…

Compare with peers

Loading peers…

What you need to know

JSLL (Jeena Sikho Lifecare) runs Ayurveda hospitals, clinics and day care centres across India that treat patients with Panchakarma therapies, and sells Ayurvedic medicines to those patients and to retail and trade buyers.

Company snapshot

1stBy market cap

Ranked among 2 companies in Wellness.

What we see

Positives

✓Net margin of 27.7% — the business keeps a healthy share of every rupee it earns.

4 more signals from the filings.Sign in free to see them all

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

Metric	Mar 2022	Jun 2025	Sept 2025	Dec 2025	Mar 2026	Jun 2026
Sales	75 Cr	174 Cr	190 Cr	222 Cr	216 Cr	224 Cr
Operating expenses (approx.)	66 Cr	96 Cr	98 Cr	121 Cr	138 Cr	132 Cr
EBITDA	9 Cr	79 Cr	92 Cr	101 Cr	78 Cr	92 Cr
OPM %	12.0%	45.2%	48.5%	45.4%	36.1%	41.0%
Other income	0.28 Cr	1 Cr	1 Cr	3 Cr	3 Cr	14 Cr
Interest	0.51 Cr	2 Cr	4 Cr	3 Cr	4 Cr	3 Cr
Depreciation	2 Cr	10 Cr	10 Cr	11 Cr	16 Cr	15 Cr
Profit before tax	7 Cr	69 Cr	79 Cr	89 Cr	61 Cr	88 Cr
Tax %	25.9%	25.2%	25.4%	25.1%	26.4%	24.7%
Net profit	5 Cr	51 Cr	59 Cr	67 Cr	45 Cr	66 Cr
EPS (₹)	₹4.96	₹4.13	₹4.73	₹5.36	₹3.63	₹5.30

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

Metric	Mar 2022	Mar 2026	TTM
Sales	147 Cr	801 Cr	Sign in free for the trailing twelve months
Operating expenses (approx.)	129 Cr	452 Cr	Sign in free for the trailing twelve months
EBITDA	18 Cr	349 Cr	Sign in free for the trailing twelve months
OPM %	12.3%	43.6%	Sign in free for the trailing twelve months
Other income	1 Cr	8 Cr	Sign in free for the trailing twelve months
Interest	1 Cr	13 Cr	Sign in free for the trailing twelve months
Depreciation	3 Cr	48 Cr	Sign in free for the trailing twelve months
Profit before tax	15 Cr	297 Cr	Sign in free for the trailing twelve months
Tax %	25.8%	25.5%	Sign in free for the trailing twelve months
Net profit	11 Cr	222 Cr	Sign in free for the trailing twelve months
EPS (₹)	₹11.11	₹17.84	Sign in free for the trailing twelve months
Dividend payout %	0.0%	6.2%	Sign in free for the trailing twelve months

The latest four quarters added up, next to each full year

Balance sheet

Annual · ₹ Cr · tap + rows to expand

Metric	Mar 2022	Mar 2026
Equity capital	10 Cr	25 Cr
Reserves	26 Cr	442 Cr
Borrowings	7 Cr	0.45 Cr
Other liabilities	18 Cr	207 Cr
Total liabilities	62 Cr	674 Cr
Fixed assets (net)	28 Cr	118 Cr
CWIP	5 Cr	2 Cr
Investments	0 Cr	110 Cr
Loans & advances	3 Cr	0 Cr
Inventories	6 Cr	20 Cr
Trade receivables	9 Cr	70 Cr
Cash & bank	3 Cr	16 Cr
Other assets	7 Cr	338 Cr
Total assets	62 Cr	674 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

Metric	Mar 2022	Mar 2026
Cash from operating activity	16 Cr	254 Cr
Cash from investing	-18 Cr	-202 Cr
Cash from financing	-5 Cr	-59 Cr
Net cash flow	-6 Cr	-7 Cr
Free cash flow (OCF − Capex)	-0.73 Cr	220 Cr

Ratios

Metric	Mar 2022	Mar 2026
ROCE %	37.0%	66.4%
ROE %	30.8%	47.5%
Debtor days	22	32
Inventory days	16	9
Days payable	12	11
Cash conversion cycle	27	30
OCF / EBITDA %	90.6%	72.6%
Debt / equity	0.20	0.0010
Current ratio	0.90	3.25
Net debt / EBITDA	0.27	-0.05